Technology | Magnetic Resonance Imaging (MRI) | September 07, 2016

GE Gains FDA Clearance for Multi-Contrast MRI in a Single Acquisition

510(k) cleared MAGiC imaging technique delivers eight contrasts in a single acquisition in fraction of the time of conventional imaging

Magic, sigma Pioneer, GE, multiple contrasts in one MRI scan

An example of a Magic MRI scan that created six different contrasts from a single contrast scan. 

September 7, 2016 – The U.S. Food and Drug Administration (FDA) granted market clearance for GE Healthcare’s MAGiC (MAGnetic resonance image Compilation) software, the industry’s first multi-contrast magnetic resonance imaging (MRI) technique that delivers eight contrasts in a single acquisition in fraction of the time of conventional imaging.

MAGiC is the result of a collaboration with SyntheticMR AB and gives clinicians more data than conventional scanning. This technique gives users the flexibility to manipulate MR images retrospectively leading to significant timesaving, fewer rescans and therefore cost savings, which combined, can assist the clinician in making a more decisive diagnosis.

MAGiC is an acquisition technique that allows the ability to modify image contrast after scanning has been completed, which is not possible with conventional imaging. GE said MAGiC delivers more potential for the clinician to utilize changes in the image contrast to enhance their diagnosis. With conventional imaging, a radiologist may need to order a rescan if the proper contrast was not acquired, requiring the patient to return and the technologist to conduct another scan. With MAGiC, the radiologist can view multiple different contrasts acquired from a single scan.

"MAGIC simultaneously provides a new level of protocol efficiency and tissue characterization,” said Howard Rowley, M.D., professor of radiology, neurology and neurosurgery at the University of Wisconsin – Madison, and president of the American Society of Neuroradiology. “The flexibility to post-process a wide variety of key image families with different tissue contrasts from a single acquisition is groundbreaking. This will be a major advance for fast brain protocols and patient comfort due to the reduced scan time."

GE Healthcare has conducted and submitted to the U.S. FDA a blinded 1.5T and 3.0T, multi-center, multi-reader clinical study comparing MAGiC to conventional scanning. This study involved both MAGiC and conventional images collected from six sites and 109 patients that were evaluated by seven readers. The study verified that the image quality of MAGiC was comparable to conventional images at a fraction of the scan time, which may improve patient throughput and comfort.

For the first, clinicians will have the ability to generate multiple image contrasts in a single MR scan – including T1, T2, STIR, T1 FLAIR, T2 FLAIR, Dual IR, Phase Sensitive IR, and Proton Density weighted images of the brain in a single acquisition. To change the contrast, users simply move the cursor on the interface to change the parameters such as TR, TE and TI. MAGiC enables one scan that can do the work of many and can be processed in many unique and independent ways.

Additionally, MAGiC can generate parametric maps enabling further tissue analysis, which is key in the emerging approach of precision medicine. The measurement of tissue values like T1, T2 and PD gives clinicians more information and therefore better insights into the disease of that specific patient, leading to a more confident diagnosis.

“MAGiC is a terrific clinical innovation,” said Eric Stahre, president and CEO, GE Healthcare MR. “This study proves that this technique can improve the way clinicians conduct neuro scans and diagnose their patients. Neuro scans are approximately thirty percent of all MR scans; therefore MAGiC could have a tremendous impact on the MR community. GE Healthcare is committed to delivering industry-leading MR innovations that advance clinical care. We are very excited to be the first company to bring MAGiC to market for our customers and their patients. ”

MAGiC is available on GE’s Optima MR450, Optima MR450w, Discovery MR750, Discovery MR750w and Signa Pioneer MRI systems.

For more information: www.gehealthcare.com, www.symri.com

Related Content

Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
Machine Learning IDs Markers to Help Predict Alzheimer's

Neurologists use structural and diffusion magnetic resonance imaging (MRI) to identify changes in brain tissue (both gray and white matter) that are characteristic of Alzheimer's disease and other forms of dementia. The MRI images are analyzed using morphometry and tractography techniques, which detect changes in the shape and dimensions of the brain and in the tissue microstructure, respectively. In this example, the images show the normal brain of an elderly patient. Image courtesy of Jiook Cha.

News | Neuro Imaging | September 20, 2018
New research has shown a combination of two different modes of magnetic resonance imaging (MRI), computer-based...
Ingenia Ambition X 1.5T MR. This innovation is the latest advance in the Ingenia MRI portfolio, which comprises fully-digital MRI systems, healthcare informatics and a range of maintenance and life cycle services for integrated solutions that empower a faster, smarter, and simpler path to enabling a confident diagnosis
News | Magnetic Resonance Imaging (MRI) | September 14, 2018
Philips, a global leader in health technology, launched the Ingenia Ambition X 1.5T MR.
Veye Chest version 2
News | Lung Cancer | September 11, 2018
Aidence, an Amsterdam-based medical AI company, announced that Veye Chest version 2, a class IIa medical device, has
Sponsored Content | Case Study | Magnetic Resonance Imaging (MRI) | September 07, 2018 | By Sabine Sartoretti, M.D.
As soon as the Compressed SENSE technology became available to the MRI team at Kantonsspital Winterthur (Switzerland),...

Image courtesy of Philips Healthcare

Feature | Magnetic Resonance Imaging (MRI) | September 06, 2018 | By Melinda Taschetta-Millane
According to the Prescient & Strategic Intelligence report, “Global Magnetic Resonance Imaging (MRI) Market Size,...
Brain Iron Levels May Predict Multiple Sclerosis Disabilities
News | Neuro Imaging | August 31, 2018
A new, highly accurate magnetic resonance imaging (MRI) technique can monitor iron levels in the brains of multiple...
Study Finds Multiple Sclerosis Drug Slows Brain Shrinkage

An NIH-funded clinical trial suggested that the anti-inflammatory drug ibudilast may slow brain shrinkage caused by progressive MS. Image courtesy of Robert J. Fox, M.D., Cleveland Clinic.

News | Neuro Imaging | August 30, 2018
August 30, 2018 — Results from a clinical...
Rapid Cardiac MRI Technique May Cut Costs, Boost Care in Developing World
News | Magnetic Resonance Imaging (MRI) | August 29, 2018
A newly developed rapid imaging protocol quickly and cheaply diagnosed heart ailments in patients in Peru, according to...
iSchemaView RAPID Technology Now Installed in More Than 500 Stroke Centers
News | Neuro Imaging | August 27, 2018
iSchemaView announced that more than 575 stroke centers in 22 countries have selected the RAPID advanced imaging...